Establishment of Optimal Transfusion Threshold During Spine Surgery
1 other identifier
interventional
60
1 country
1
Brief Summary
The purpose of this study is to determine whether a higher threshold for transfusion with red blood cells improves the tissue oxygenation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2009
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 24, 2009
CompletedFirst Posted
Study publicly available on registry
August 27, 2009
CompletedStudy Start
First participant enrolled
September 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2011
CompletedFebruary 25, 2011
February 1, 2011
1.3 years
August 24, 2009
February 24, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The change in subcutaneous oxygen tension from incision.
The primary endpoint is the change in subcutaneous oxygen tension from incision until the time most patients is still undergoing surgery. Subcutaneous oxygen tension is measured every fifteen minutes throughout surgery. The oxygen tension is measured with a polygraphic electrode (Clark's electrode).
Every fifteen minutes throughout surgery
Secondary Outcomes (5)
Oxygenation of the brain
Every fifteen minutes throughout surgery
The concentration of lactate in plasma
Every half an hour throughout surgery
Variation in the ST-segment of the ECG
Every fifteen minutes throughout surgery
Muscular saturation of the deltoid muscle
Every fifteen minutes throughout surgery
The change in subcutaneous oxygen tension from incision.
Every fifteen minutes throughout surgery
Study Arms (2)
Allowed drop in hemoglobin to 4,5-5,5 mmol/L
ACTIVE COMPARATORTransfusion with red blood cells to level between 4.5-5.5 mmol/L
Allowed drop in hemoglobin to 5,5-6,5 mmol/L
EXPERIMENTALTransfusion with red blood cells to level between 5.5-6.5 mmol/L
Interventions
Transfusion with red blood cells to hemoglobin level between 4,5-5,5 mmol/L
Transfusion with red blood cells to hemoglobin level between 5,6-6,5 mmol/L
Eligibility Criteria
You may qualify if:
- years or older
- Patients undergoing spine surgery
- Be legally competent
- Read and understand Danish
You may not qualify if:
- Present malignant disease
- Previously apoplexia cerebri
- Known heart disease with functionality equivalent to NYHA II or CCS II or worse
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Rigshospitalet, Denmarklead
- TrygFonden, Denmarkcollaborator
Study Sites (1)
Rigshospitalet
Copenhagen, Østerbro, 2100, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kamilla Nielsen, MD
Rigshospitalet, Denmark
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
August 24, 2009
First Posted
August 27, 2009
Study Start
September 1, 2009
Primary Completion
January 1, 2011
Study Completion
February 1, 2011
Last Updated
February 25, 2011
Record last verified: 2011-02